New Delhi, April 15, 2023: A new sandwich based lateral flow immunoassay (LFIA) for the detection of Receptor Binding Domain (RBD) of severe acute respiratory syndrome-coronavirus-2( SARS-CoV-2) could provide an efficient substitute for RT-PCR tests. It can detect that RBD antigen of the SARS-CoV-2 at an early stage of infection with a visual line of […]
Tag: SARS-CoV-2
Covaxin can help in controlling the virus load of SARS-CoV-2 & its variants, reducing disease severity
New Delhi, July 28, 2022: Scientists have found that Covaxin, which is an inactivated whole-virion vaccine, induces robust immune memory to SARS-CoV-2 and variants of concern that persist for at least 6 months after vaccination and induces memory T cells that can respond robustly against the variants. Covaxin may help in controlling the virus load […]
Scientists develop novel mechanism to inactivate SARS-CoV-2 by blocking their entry to cells & reducing infection ability
New Delhi, July 20, 2022: Researchers have reported the design of a new class of synthetic peptides that can not only block the entry of SARS-CoV-2 virus entry into cells but also clump the virions (virus particles) together, reducing their ability to infect. This novel approach provides an alternative mechanism to render viruses like SARS-CoV-2 […]
Scientists develop new platform to detect SARS-CoV-2 by fluorescence readout
New Delhi, February 23, 2022: A team of scientists has developed a new technology, platform for fluorometric detection of pathogens such as viruses by measurement of fluorescent light emitted. The potential of the new technology has been demonstrated for the detection of SARS-CoV-2. This technology platform can also be used to detect other DNA/RNA pathogens […]
Effectiveness of COVISHIELD against the delta variant of SARS-CoV-2
New Delhi, December 8, 2021: SARS-CoV-2 has affected more than 200 million people causing more than 5 million deaths worldwide as per the WHO statistics. The rise in mutant variants of SARS-CoV-2 virus has led to concerns regarding vaccine effectiveness. Delta (B.1.617.2) variant is the predominant strain in India. The vaccination programme in India is […]